S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)
S&P 500   4,584.12 (+0.37%)
DOW   36,217.89 (+0.26%)
QQQ   390.03 (+0.71%)
AAPL   194.15 (+0.38%)
MSFT   374.71 (+0.59%)
META   320.70 (+0.76%)
GOOGL   131.65 (+0.50%)
AMZN   147.90 (+0.69%)
TSLA   243.03 (+1.81%)
NVDA   471.75 (+1.31%)
NIO   7.64 (+2.83%)
BABA   72.47 (+0.12%)
AMD   120.23 (+1.56%)
T   17.21 (-0.06%)
F   10.69 (+0.85%)
MU   74.75 (+1.44%)
CGC   0.71 (+6.12%)
GE   120.73 (+0.42%)
DIS   91.48 (+0.76%)
AMC   7.09 (+1.00%)
PFE   29.14 (+0.17%)
PYPL   57.81 (-0.19%)
XOM   100.17 (-0.27%)

Teleflex Stock Price, News & Analysis (NYSE:TFX)

$227.56
-1.80 (-0.78%)
(As of 12/5/2023 ET)
Compare
Today's Range
$225.15
$230.17
50-Day Range
$179.39
$229.36
52-Week Range
$177.63
$276.43
Volume
203,816 shs
Average Volume
306,316 shs
Market Capitalization
$10.70 billion
P/E Ratio
26.68
Dividend Yield
0.60%
Price Target
$258.40

Teleflex MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
13.6% Upside
$258.40 Price Target
Short Interest
Healthy
2.53% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.76mentions of Teleflex in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$3.11 M Sold Last Quarter
Proj. Earnings Growth
3.50%
From $13.41 to $13.88 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

Medical Sector

31st out of 948 stocks

Surgical & Medical Instruments Industry

9th out of 82 stocks


TFX stock logo

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

TFX Stock News Headlines

Teleflex (NYSE:TFX) Stock Rating Upgraded by Morgan Stanley
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Morgan Stanley Upgrades Teleflex (TFX)
Returns On Capital At Teleflex (NYSE:TFX) Have Stalled
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Teleflex (NYSE:TFX) Upgraded to Buy by StockNews.com
Q3 2023 Teleflex Inc Earnings Call
Teleflex Gains 10% After Q3 Results Surpass Estimates
Teleflex Inc (TFX) Reports 8.7% Revenue Growth in Q3 2023
Teleflex: Q3 Earnings Snapshot
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 9/15 Dividend
9/14/2023
Dividend Payable
9/15/2023
Last Earnings
11/02/2023
Ex-Dividend for 12/15 Dividend
11/14/2023
Today
12/06/2023
Dividend Payable
12/15/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/22/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
15,500
Year Founded
1943

Price Target and Rating

Average Stock Price Target
$258.40
High Stock Price Target
$293.00
Low Stock Price Target
$221.00
Potential Upside/Downside
+13.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
10 Analysts

Profitability

Net Income
$363.14 million
Pretax Margin
16.34%

Debt

Sales & Book Value

Annual Sales
$2.79 billion
Cash Flow
$18.16 per share
Book Value
$85.74 per share

Miscellaneous

Free Float
46,337,000
Market Cap
$10.70 billion
Optionable
Optionable
Beta
1.09

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report














TFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price target for 2024?

10 Wall Street analysts have issued 12-month target prices for Teleflex's stock. Their TFX share price targets range from $221.00 to $293.00. On average, they predict the company's share price to reach $258.40 in the next year. This suggests a possible upside of 13.6% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has decreased by 8.8% and is now trading at $227.56.
View the best growth stocks for 2023 here
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) issued its quarterly earnings data on Thursday, November, 2nd. The medical technology company reported $3.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.27 by $0.37. The medical technology company had revenue of $746.39 million for the quarter, compared to analysts' expectations of $734.80 million. Teleflex had a net margin of 13.65% and a trailing twelve-month return on equity of 15.52%.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, November 2nd. Investors of record on Wednesday, November 15th will be given a dividend of $0.34 per share on Friday, December 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Tuesday, November 14th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 15.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 9.80% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY23 earnings guidance on Thursday, November, 2nd. The company provided earnings per share guidance of $13.30-$13.50 for the period, compared to the consensus earnings per share estimate of $13.26.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional investors include Morgan Stanley (6.00%), Wellington Management Group LLP (5.20%), Invesco Ltd. (1.32%), TD Asset Management Inc (1.03%), Northern Trust Corp (0.97%) and Bank of New York Mellon Corp (0.88%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:TFX) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -